These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 25281195)
1. The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss - a case report. Klingele M; Seiler S; Poppleton A; Lepper P; Fliser D; Seidel R BMC Nephrol; 2014 Oct; 15():163. PubMed ID: 25281195 [TBL] [Abstract][Full Text] [Related]
2. Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation. Wang PL; Meyer MM; Orloff SL; Anderson S Am J Kidney Dis; 2004 Dec; 44(6):1110-4. PubMed ID: 15558534 [TBL] [Abstract][Full Text] [Related]
3. Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. Gupta M; Wadhwa NK; Bukovsky R Am J Kidney Dis; 2004 Jan; 43(1):67-73. PubMed ID: 14712429 [TBL] [Abstract][Full Text] [Related]
4. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients. Finkel KW; Foringer JR Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991 [TBL] [Abstract][Full Text] [Related]
5. Effects of bisphosphonates on bone loss in the first year after renal transplantation--a meta-analysis of randomized controlled trials. Mitterbauer C; Schwarz C; Haas M; Oberbauer R Nephrol Dial Transplant; 2006 Aug; 21(8):2275-81. PubMed ID: 16574684 [TBL] [Abstract][Full Text] [Related]
6. An observational study on the effects of nadroparin-based and citrate-based continuous venovenous hemofiltration on calcium metabolism. van der Voort PH; Postma SR; Kingma WP; Boerma EC; de Heide LJ; Bakker AJ Blood Purif; 2007; 25(3):267-73. PubMed ID: 17446700 [TBL] [Abstract][Full Text] [Related]
8. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy. Saner FH; Treckmann JW; Geis A; Lösch C; Witzke O; Canbay A; Herget-Rosenthal S; Kribben A; Paul A; Feldkamp T Nephrol Dial Transplant; 2012 Apr; 27(4):1651-7. PubMed ID: 22049184 [TBL] [Abstract][Full Text] [Related]
10. Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report. Wu B; Wang J; Yang G; Xing C; Mao H BMC Nephrol; 2018 Jun; 19(1):136. PubMed ID: 29898699 [TBL] [Abstract][Full Text] [Related]
11. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation. Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894 [TBL] [Abstract][Full Text] [Related]
12. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553 [TBL] [Abstract][Full Text] [Related]
13. Focus on vitamin D therapy in chronic kidney disease. Tentori F J Nephrol; 2007; 20(5):511-4. PubMed ID: 17918134 [No Abstract] [Full Text] [Related]
14. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Cointault O; Kamar N; Bories P; Lavayssiere L; Angles O; Rostaing L; Genestal M; Durand D Nephrol Dial Transplant; 2004 Jan; 19(1):171-8. PubMed ID: 14671053 [TBL] [Abstract][Full Text] [Related]
15. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Klingele M; Stadler T; Fliser D; Speer T; Groesdonk HV; Raddatz A Crit Care; 2017 Nov; 21(1):294. PubMed ID: 29187232 [TBL] [Abstract][Full Text] [Related]
16. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210 [TBL] [Abstract][Full Text] [Related]
17. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289 [TBL] [Abstract][Full Text] [Related]
18. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury. Liu DL; Huang LF; Ma WL; Ding Q; Han Y; Zheng Y; Li WX Chin Med J (Engl); 2016 Jul; 129(14):1682-7. PubMed ID: 27411455 [TBL] [Abstract][Full Text] [Related]
19. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967 [TBL] [Abstract][Full Text] [Related]
20. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Hetzel GR; Schmitz M; Wissing H; Ries W; Schott G; Heering PJ; Isgro F; Kribben A; Himmele R; Grabensee B; Rump LC Nephrol Dial Transplant; 2011 Jan; 26(1):232-9. PubMed ID: 20876598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]